U.S. FDA issues four observations to Gland Pharma formulation facility near Hyderabad
The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23
The Hindu · · 1 min read ·
The four Form 483 observations followed an unannounced inspection on current good manufacturing practice at the facility in Dundigal between October 12 and 23
More in World
World
China simplifies visa process for Indians : Direct submissions , lower fees , and key updates
World· Haryana
Haryana gangsters Himanshu Bhau, Neeraj Faridpuria detained in U.S.
Confirming the development, Haryana STF Inspector General Simardeep Singh told that both gangsters had been detained in Las Vegas
World
25-year-old student from Khammam dies of suspected heart attack in U.S.
World
Why is ITBP overhauling its training and combat strategy along the China border? Explained
The ITBP was formed on October 24, 1962 after the Indo-China war